However, the CpGs in TRIM59 showed hypermethylation in the group of early onset Alzheimer’s disease as well as Graves’ disease patients while the CpGs in FHL2 showed hypomethylation in the latter. Here, FHL2 is linked to early-onset autosomal dominant Alzheimer disease.